About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Pittsburgh | 10,700 Studies Near You

Clinical TrialsPittsburgh

Clinical Trials in Pittsburgh

Discover 10,700 clinical trials near Pittsburgh, Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3241-3260 of 10,700 trials

CompletedSexual and Gender Minority Youth (SGMY) and Online Interventions to Increase Help-seeking for Anxiety and/or Depressionthe investigators will use 4 technology based tools (combinations of youtube videos, links to online resources, tiktok videos, and other media) in a study of 96 Sexual and Gender…NCT06083987·Pittsburgh, Pennsylvania CompletedMAVRIC VR ICD RegistryThe purpose of this registry is to collect information on the health status of patients receiving Marquis/Maximo VR Implantable Cardiac Defibrillators (ICDs), how the devices are…NCT00270933·Birmingham, Alabama and 90 others

Find Trials by Condition in Pittsburgh

Breast Cancerin Pittsburgh Lung Cancerin Pittsburgh Prostate Cancerin Pittsburgh Colorectal Cancerin Pittsburgh Melanomain Pittsburgh Leukemiain Pittsburgh Lymphomain Pittsburgh Pancreatic Cancerin Pittsburgh Ovarian Cancerin Pittsburgh Brain Cancerin Pittsburgh

Data from ClinicalTrials.govTerms

Approved for marketingEAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerThis study will provide pre-approval drug access to lapatinib, in combination with capecitabine, to patients whose breast cancer had progressed on other therapiesNCT00338247·Huntsville, Alabama and 452 others

CompletedEarly ART to Limit Infection and Establishment of ReservoirThe study was done to: * Start antiretroviral therapy (ART) early in those recently or acutely infected with HIV-1 * See how starting ART as soon as the infection is found…NCT02859558·Birmingham, Alabama and 29 others

RecruitingPhase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaThis study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).NCT04234048·Scottsdale, Arizona and 9 others

TerminatedBETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus BevacizumabThe trial will determine the value of adding bevacizumab to chemotherapy plus trastuzumab in patients with resected node-positive or high risk node-negative, HER2-positive breast…NCT00625898·Birmingham, Alabama and 648 others

RecruitingProspective Investigation of Multiple Sclerosis in the Three Rivers RegionIn this longitudinal prospective natural history study of multiple sclerosis (MS), the overarching goal is to understand the factors that influence individual variation in disease…NCT02994121·Pittsburgh, Pennsylvania

CompletedStudy of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic CancerTo compare the efficacy of pegilodecakin in combination with FOLFOX versus FOLFOX alone in participants with metastatic pancreatic cancer as measured by overall survival.NCT02923921·Gilbert, Arizona and 129 others

CompletedAPR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)A Phase III, multicenter, randomized study to compare the rate of complete response (CR) and duration of CR, in patients with TP53-mutated MDS who will receive APR-246 and…NCT03745716·Duarte, California and 26 others

CompletedA Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to UstekinumabThe purpose of this study is to evaluate the efficacy and safety of guselkumab (CNTO 1959) in the treatment of participants with moderate to severe plaque-type psoriasis (scaly…NCT02203032·Birmingham, Alabama and 84 others

Active not recruitingStudy Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)This is a Phase 1/2, open-label, multicenter study to determine the efficacy and safety of JCAR017 in adult subjects with relapsed or refractory CLL or SLL.NCT03331198·Birmingham, Alabama and 83 others

CompletedT2Resistance - Detection of Resistance Related GenesThe purpose of this study is to evaluate the safety and effectiveness of the T2Resistance Panel by validating clinical performance in three study arms: 1.NCT05231187·Birmingham, Alabama and 9 others

CompletedStreamlining Trauma Research Evaluation With Advanced MeasurementThe STREAM Study is a prospective longitudinal observational outcomes study that will examine the reliability, validity and responsiveness of the PROMIS tools for clinical…NCT02079714·Birmingham, Alabama and 43 others

RecruitingA Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric CancerThis is a double-blind, randomized, multiregion, comparative phase Ⅲ clinical study designed to evaluate the efficacy and safety of HLX22 in combination with trastuzumab and…NCT06532006·Anaheim, California and 207 others

RecruitingGORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval StudyA prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as…NCT07166133·Scottsdale, Arizona and 19 others

CompletedStudy of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With SunitinibThis study is designed to determine the clinical efficacy and toxicity of ABT 869 in the treatment of subjects with advanced renal cell carcinoma who have previously received…NCT00486538·Sacramento, California and 12 others

CompletedStudy Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate VaccineThe purpose of this study is to evaluate the safety, tolerability, and immunogenicity of the 13-valent pneumococcal vaccine (13vPnC) compare to the 7-valent pneumococcal vaccine…NCT00373958·Fayetteville, Arkansas and 36 others

CompletedA Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque PsoriasisThe main aim of this study is to assess whether zasocitinib works better than deucravacitinib in treating participants with moderate-to-severe plaque psoriasis.NCT06973291·Fort Smith, Arkansas and 112 others

CompletedStandard vs. Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary EmbolismThe study will compare standard catheter directed thrombolysis to ultrasound accelerated thrombolysis for the treatment of acute submassive pulmonary embolism (PE).NCT02758574·Pittsburgh, Pennsylvania and 3 others

CompletedDemonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose* Whether a combination of three therapies - metformin and a sulfonylurea plus Exubera, an investigational drug, controls your diabetes at least as much as a triple combination…NCT00150410·Mesa, Arizona and 118 others

PreviousPage 163 of 535Next

Diabetes

in Pittsburgh

Heart Diseasein Pittsburgh